"10.1371_journal.pone.0030994","plos one","2012-02-16T00:00:00Z","Colton Linnertz; Ann M Saunders; Michael W Lutz; Donna M Crenshaw; Iris Grossman; Daniel K Burns; Keith E Whitfield; Michael A Hauser; Jeanette J McCarthy; Megan Ulmer; Rand Allingham; Kathleen A Welsh-Bohmer; Allen D Roses; Ornit Chiba-Falek","Institute for Genome Sciences & Policy, Duke University, Durham, North Carolina, United States of America; Deane Drug Discovery Institute, Duke University Medical Center, Durham, North Carolina, United States of America; Division of Neurology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America; Cabernet Pharmaceuticals, Chapel Hill, North Carolina, United States of America; Department of Psychology and Neuroscience, Duke University, Durham, North Carolina, United States of America; Center for Human Genetics, Duke University Medical Center, Durham, North Carolina, United States of America; Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America; Joseph and Kathleen Bryan Alzheimers Disease Research Center, Duke University, Durham, North Carolina, United States of America; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, United States of America","Conceived and designed the experiments: AMS ADR OC-F. Performed the experiments: CL. Analyzed the data: AMS MWL DMC IG DKB ADR OC-F. Contributed reagents/materials/analysis tools: KEW MAH JJM MU RA KAW-B OC-F. Wrote the paper: AMS MWL DMC ADR OC-F.","ADR is the CEO of Cabernet Pharmaceuticals, Inc., a pipeline pharmacogenetics consultation and project management company; and CEO of Zinfandel Pharmaceuticals, Inc., who is in an alliance with Takeda Pharmaceuticals to perform a delay of onset trial for dementias of the Alzheimer type. AMS, MWL and DMC are Members of the Joint Biomarker Committee for the Zinfandel-Takeda Alliance clinical trial and AMS is the spouse of ADR. DKB is a Senior VP of Zinfandel Pharmaceuticals. International Application No: PCT/US2009/053373: Method of identifying disease risk factors. Assignee: Zinfandel Pharmaceuticals, Inc; Inventor: Allen D. Roses. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","02","Colton Linnertz","CL",14,TRUE,3,1,7,5,TRUE,FALSE,FALSE,0,NA,FALSE
